stockportfolio.pro
TG Therapeutics, Inc. EPS (Earnings per Share) 2011–2025
TG Therapeutics, Inc. (TGTX) annual earnings per share by fiscal year, computed from SEC filings.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $2.77 | +1746.7% |
| FY 2024 | $0.15 | +66.7% |
| FY 2023 | $0.09 | +105.5% |
| FY 2022 | $-1.65 | +37.3% |
| FY 2021 | $-2.63 | -8.7% |
| FY 2020 | $-2.42 | — |
| FY 2019 | $0.00 | — |
| FY 2018 | $0.00 | — |
| FY 2017 | $0.00 | — |
| FY 2016 | $0.00 | — |
| FY 2015 | $0.00 | — |
| FY 2014 | $0.00 | — |
| FY 2013 | $0.00 | — |
| FY 2012 | $0.00 | — |
| FY 2011 | $0.00 | — |
Source: TG Therapeutics, Inc. SEC filings — income statement (10-K), split-adjusted. Refreshed nightly.
See the full picture for TG Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTG Therapeutics, Inc. — frequently asked questions
What is TG Therapeutics, Inc.'s earnings per share?
TG Therapeutics, Inc. (TGTX) reported earnings per share of $2.77 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from TG Therapeutics, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.